Laridae – Talk Bio

Actionable Insights Powered by AI

Terns Pharmaceuticals’ Oral GLP-1 Drug Demonstrates Promising Weight Loss Results

8 months ago talkbio0Tagged Glucagon-Like Peptide 1, Laridae, Obesity, Oral cavity, TERN-601, Weight Loss

Terns Pharmaceuticals, Oral GLP-1, Weight Loss, Obesity Treatment, TERN-601

Terns Pharmaceuticals’ Oral GLP-1R Agonist TERN-601 Shows Promising Weight Loss in Phase 1 Trial

8 months ago talkbio0Tagged Agonist, Laridae, Obesity, Oral cavity, phase 1 trial, TERN-601, Weight Loss

Terns Pharmaceuticals, TERN-601, Oral GLP-1R Agonist, Phase 1 Trial, Weight Loss, Obesity Treatment